GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Science Strategic Acquisition Corp Alpha (NAS:SSAAU) » Definitions » Capex-to-Revenue

Science Strategic Acquisition Alpha (Science Strategic Acquisition Alpha) Capex-to-Revenue : 0.00 (As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Science Strategic Acquisition Alpha Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Science Strategic Acquisition Alpha's Capital Expenditure for the three months ended in Sep. 2022 was $0.00 Mil. Its Revenue for the three months ended in Sep. 2022 was $0.00 Mil.

GuruFocus do not calculate Capex-to-Revenue if the revenue is negative.


Science Strategic Acquisition Alpha Capex-to-Revenue Historical Data

The historical data trend for Science Strategic Acquisition Alpha's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Science Strategic Acquisition Alpha Capex-to-Revenue Chart

Science Strategic Acquisition Alpha Annual Data
Trend Dec20 Dec21
Capex-to-Revenue
- -

Science Strategic Acquisition Alpha Quarterly Data
Oct20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Capex-to-Revenue Get a 7-Day Free Trial - - - - -

Competitive Comparison of Science Strategic Acquisition Alpha's Capex-to-Revenue

For the Shell Companies subindustry, Science Strategic Acquisition Alpha's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Science Strategic Acquisition Alpha's Capex-to-Revenue Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Science Strategic Acquisition Alpha's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Science Strategic Acquisition Alpha's Capex-to-Revenue falls into.



Science Strategic Acquisition Alpha Capex-to-Revenue Calculation

Science Strategic Acquisition Alpha's Capex-to-Revenue for the fiscal year that ended in Dec. 2021 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0
=N/A

Science Strategic Acquisition Alpha's Capex-to-Revenue for the quarter that ended in Sep. 2022 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Science Strategic Acquisition Alpha  (NAS:SSAAU) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Science Strategic Acquisition Alpha Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Science Strategic Acquisition Alpha's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Science Strategic Acquisition Alpha (Science Strategic Acquisition Alpha) Business Description

Traded in Other Exchanges
N/A
Address
1447 2nd Street, Suite 200, Santa Monica, CA, USA, 90401
Science Strategic Acquisition Corp Alpha is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
Executives
Michael Gwynne Jones director, officer: CEO 24460 MALIBU ROAD, MALIBU CA 90265
Jeff Kearl director C/O SKULLCANDY, INC., 1441 WEST UTE BLVD., SUITE 250, PARK CITY UT 84908
April Henry officer: EVP, Corporate Development C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Jennifer Rubio director C/O TISHMAN SPEYER PROPERTIES, L.P., ROCKEFELLER CENTER, 45 ROCKEFELLER PLAZA, NEW YORK NY 10111
Taylor Colette K. director C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Greg Gilman director C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Priscilla Guevara officer: Global Head of IR C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Tom Dare officer: CFO C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Peter Pham officer: President C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401

Science Strategic Acquisition Alpha (Science Strategic Acquisition Alpha) Headlines

No Headlines